These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 7788958
1. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group. Fong IW, Laforge J, Dubois J, Small D, Grossman R, Zakhari R. Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958 [Abstract] [Full Text] [Related]
2. Treatment of acute bronchitis and pneumonia with cefaclor. Mattson K, Renkonen OV, Laitinen L, Nikander-Hurme R. Postgrad Med J; 1979 Apr; 55 Suppl 4():59-61. PubMed ID: 398482 [Abstract] [Full Text] [Related]
5. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections. Rocha RT, Awad CE, Ali A, Matyas R, Vital AC, Silva CO, Dainesi SM, Salazar MS, Nakatani J. Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070 [Abstract] [Full Text] [Related]
6. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis. Alanis A, Longest KA, Senetar JE, Dere WH. Postgrad Med J; 1992 Sep; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614 [Abstract] [Full Text] [Related]
7. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L. Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [Abstract] [Full Text] [Related]
8. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection. Quenzer RW, Pettit KG, Arnold RJ, Kaniecki DJ. Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367 [Abstract] [Full Text] [Related]
13. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. Wettengel R, Vetter N, Waardenburg FA. J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133 [Abstract] [Full Text] [Related]
14. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis. Gotfried M, Notario G, Spiller J, Palmer R, Busman T. Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995 [Abstract] [Full Text] [Related]
18. Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis. Smialowicz CR. Clin Ther; 1982 Feb; 5(2):113-9. PubMed ID: 7159894 [Abstract] [Full Text] [Related]
19. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin. Nalepa P, Dobryniewska M, Busman T, Notario G. Curr Med Res Opin; 2003 Feb; 19(5):411-20. PubMed ID: 13678478 [Abstract] [Full Text] [Related]
20. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin. Beumer HM, Veldkamp J. Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283 [Abstract] [Full Text] [Related] Page: [Next] [New Search]